Nobuto Tsuneyama

518 total citations
29 papers, 335 citations indexed

About

Nobuto Tsuneyama is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Nobuto Tsuneyama has authored 29 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Nobuto Tsuneyama's work include Schizophrenia research and treatment (12 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Diet and metabolism studies (6 papers). Nobuto Tsuneyama is often cited by papers focused on Schizophrenia research and treatment (12 papers), Cardiac electrophysiology and arrhythmias (7 papers) and Diet and metabolism studies (6 papers). Nobuto Tsuneyama collaborates with scholars based in Japan and United Kingdom. Nobuto Tsuneyama's co-authors include Yutaro Suzuki, Toshiyuki Someya, Takuro Sugai, Naoki Fukui, Shin Ono, Junzo Watanabe, Mami Saito, Yoshimasa Inoue, Kazushi Sawamura and Yuichiro Watanabe and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Affective Disorders.

In The Last Decade

Nobuto Tsuneyama

29 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuto Tsuneyama Japan 12 161 84 73 62 51 29 335
Junzo Watanabe Japan 15 203 1.3× 97 1.2× 65 0.9× 112 1.8× 57 1.1× 31 466
Frederik Vandenberghe Switzerland 10 148 0.9× 29 0.3× 60 0.8× 32 0.5× 87 1.7× 33 302
Niclas Lunder Norway 7 133 0.8× 23 0.3× 62 0.8× 96 1.5× 82 1.6× 10 355
Michael J. Bly United States 9 157 1.0× 27 0.3× 66 0.9× 99 1.6× 99 1.9× 12 372
Shingo Ono Japan 13 270 1.7× 32 0.4× 28 0.4× 53 0.9× 27 0.5× 39 494
Niko Seppälä Finland 12 251 1.6× 18 0.2× 30 0.4× 55 0.9× 61 1.2× 20 398
Jean-Louis Golmard France 7 141 0.9× 28 0.3× 28 0.4× 32 0.5× 36 0.7× 8 321
Kazushi Sawamura Japan 10 128 0.8× 17 0.2× 28 0.4× 117 1.9× 34 0.7× 15 374
Jarbas S. Roriz‐Filho Brazil 7 55 0.3× 40 0.5× 117 1.6× 59 1.0× 178 3.5× 11 447

Countries citing papers authored by Nobuto Tsuneyama

Since Specialization
Citations

This map shows the geographic impact of Nobuto Tsuneyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuto Tsuneyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuto Tsuneyama more than expected).

Fields of papers citing papers by Nobuto Tsuneyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuto Tsuneyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuto Tsuneyama. The network helps show where Nobuto Tsuneyama may publish in the future.

Co-authorship network of co-authors of Nobuto Tsuneyama

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuto Tsuneyama. A scholar is included among the top collaborators of Nobuto Tsuneyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuto Tsuneyama. Nobuto Tsuneyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Yuichiro, et al.. (2023). Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia. Scientific Reports. 13(1). 1148–1148. 13 indexed citations
2.
Suzuki, Yutaro, et al.. (2023). Association between insulin resistance and serum insulin-like growth factor 1 levels in patients with non-remitting major depressive disorder. Journal of Affective Disorders. 344. 612–616. 3 indexed citations
3.
Suzuki, Yutaro, et al.. (2021). Role of insulin-like growth factor 1, sex and corticosteroid hormones in male major depressive disorder. BMC Psychiatry. 21(1). 157–157. 10 indexed citations
4.
Suzuki, Yutaro, et al.. (2019). Hormonal Dynamics Effect of Serum Insulin-Like Growth Factor I and Cortisol/Dehydroepiandrosterone Sulfate Ratio on Symptom Severity of Major Depressive Disorder. Journal of Clinical Psychopharmacology. 39(4). 367–371. 8 indexed citations
5.
Suzuki, Yutaro, et al.. (2018). Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia. PLoS ONE. 13(7). e0199922–e0199922. 4 indexed citations
6.
Tsuneyama, Nobuto, Yutaro Suzuki, Kazushi Sawamura, et al.. (2016). Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia. PLoS ONE. 11(3). e0149518–e0149518. 11 indexed citations
7.
8.
Fukui, Naoki, Yutaro Suzuki, Takuro Sugai, et al.. (2014). Promoter variation in the catechol-O-methyltransferase gene is associated with remission of symptoms during fluvoxamine treatment for major depression. Psychiatry Research. 218(3). 353–355. 6 indexed citations
9.
Suzuki, Yutaro, Takuro Sugai, Shin Ono, et al.. (2014). Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia. Psychiatry and Clinical Neurosciences. 68(5). 353–356. 6 indexed citations
10.
Suzuki, Yutaro, Takuro Sugai, Naoki Fukui, et al.. (2013). Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics. Schizophrenia Research. 145(1-3). 116–119. 15 indexed citations
11.
Suzuki, Yutaro, Nobuto Tsuneyama, Naoki Fukui, et al.. (2013). Impact of the ABCB1 Gene Polymorphism on Plasma 9-Hydroxyrisperidone and Active Moiety Levels in Japanese Patients With Schizophrenia. Journal of Clinical Psychopharmacology. 33(3). 411–414. 21 indexed citations
12.
Ono, Shin, Yutaro Suzuki, Naoki Fukui, et al.. (2013). The Prevalence of Glucose Intolerance in Japanese Schizophrenic Patients With a Normal Fasting Glucose Level. Journal of Clinical Psychopharmacology. 33(4). 525–527. 4 indexed citations
13.
Suzuki, Yutaro, Takuro Sugai, Naoki Fukui, et al.. (2013). Sex differences in the effect of four second‐generation antipsychotics on QTc interval in patients with schizophrenia. Human Psychopharmacology Clinical and Experimental. 28(3). 215–219. 15 indexed citations
14.
Sugai, Takuro, Yutaro Suzuki, Naoki Fukui, et al.. (2012). Excessive Insulin Secretion in Japanese Schizophrenic Patients Treated With Antipsychotics Despite Normal Fasting Glucose Levels. Journal of Clinical Psychopharmacology. 32(6). 750–755. 5 indexed citations
15.
Suzuki, Yutaro, Takuro Sugai, Naoki Fukui, et al.. (2012). Changes in QT interval after switching to quetiapine in Japanese patients with schizophrenia. Human Psychopharmacology Clinical and Experimental. 28(1). 94–96. 3 indexed citations
16.
Watanabe, Junzo, Yutaro Suzuki, Takuro Sugai, et al.. (2012). The lipid profiles in Japanese patients with schizophrenia treated with antipsychotic agents. General Hospital Psychiatry. 34(5). 525–528. 8 indexed citations
17.
Watanabe, Junzo, Yutaro Suzuki, Naoki Fukui, et al.. (2011). Increased Risk of Antipsychotic-Related QT Prolongation During Nighttime. Journal of Clinical Psychopharmacology. 32(1). 18–22. 22 indexed citations
18.
Ono, Shin, Yutaro Suzuki, Naoki Fukui, et al.. (2011). Association between the GIPR gene and the insulin level after glucose loading in schizophrenia patients treated with olanzapine. The Pharmacogenomics Journal. 12(6). 507–512. 9 indexed citations
19.
Suzuki, Yutaro, Naoki Fukui, Junzo Watanabe, et al.. (2010). Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(7). 1266–1268. 14 indexed citations
20.
Suzuki, Yutaro, Kazushi Sawamura, Shin Ono, et al.. (2010). The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(6). 830–833. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junzo Watanabe Breakdown of academic impact, for papers by Frederik Vandenberghe Breakdown of academic impact, for papers by Niclas Lunder Breakdown of academic impact, for papers by Michael J. Bly Breakdown of academic impact, for papers by Shingo Ono Breakdown of academic impact, for papers by Niko Seppälä Breakdown of academic impact, for papers by Jean-Louis Golmard Breakdown of academic impact, for papers by Kazushi Sawamura Breakdown of academic impact, for papers by Jarbas S. Roriz‐Filho
Rankless by CCL
2026